KRAS and adenoma: These tumors later develop additional driver mutations, often in genes encoding the KRAS GTPase and the TP53 tumor suppressor, the latter alterations often driving transition from late-stage adenoma to invasive carcinoma (Baker et al., 1990; Naccarati et al., 2012).